alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Public Media Works, Inc. (the “Company”) on Form 10-Q for the quarter ending August 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Roffman certify in my capacity as Chief Financial Officer (principal financial officer), pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





IN WITNESS WHEREOF, the undersigned has hereunto signed as of October 17, 2011.





/s/ Ed RoffmanEd RoffmanChief Financial Officer(principal financial officer)




A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
##### 



Exhibit 10.5 CONSULTING AGREEMENT This Consulting Agreement (hereinafter Agreement) made and entered into this 10th
day of May, 2004 (the Effective Date) by and between aaiPharma Inc., a Delaware corporation,
having its principal place of business at 2320 Scientific Park Drive, Wilmington, North Carolina
28405, including its subsidiaries, (hereinafter aaiPharma) and William L. Ginna, Jr., with an
address of 1200 Clipper Lane, Wilmington, NC 28405 (hereinafter Consultant). W I T N E S S E T H WHEREAS, aaiPharma desires to have Consultant perform certain consulting services for and on
behalf of aaiPharma; NOW THEREFORE, in consideration of the mutual covenants and agreements set forth hereinafter
and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties do hereby agree as follows: ARTICLE I
SERVICES Consultant shall render consulting services as reasonably requested by the Chief Executive
Officer involving activities that Consultant was engaged in on behalf of aaiPharma prior to the
Effective Date or as otherwise agreed to by Consultant and aaiPharmas Chief Executive Officer.
Consultant agrees that he shall be available during aaiPharmas normal business hours May 11, 2004
through May 10, 2005. ARTICLE II
COMPENSATION aaiPharma Inc. shall pay Consultant the Consulting Payment as that term is defined in the
letter dated May 10, 2004 from aaiPharma to Consultant (the Letter Agreement). ARTICLE III
TERM AND TERMINATION This Agreement shall commence on May 11, 2004 and terminate on May 10, 2005 unless terminated
earlier as set forth in the Letter Agreement. ARTICLE IV
CONFIDENTIALITY The terms of the Confidentiality Agreement dated February 1, 2000 between Consultant and
aaiPharma Inc. are incorporated herein by reference.




---



##### 



CONSULTING AGREEMENT
Page 2 of 2 ARTICLE V
RELATIONSHIP BETWEEN THE PARTIES Consultant is retained only for the purposes and to the extent set forth in the Purpose of
this Agreement, and his relationship to aaiPharma shall be that of an independent contractor. As
such Consultant shall not be entitled to any pension, stock, bonus, profit-sharing, health, or
similar benefits which are available to aaiPharma employees. ARTICLE VI
MISCELLANEOUS This Agreement may be amended only by written instrument executed by both parties. This
Agreement shall be interpreted in accordance with the laws of the State of North Carolina. Neither
party shall be liable for consequential, punitive or exemplary damages with respect to this
Agreement. IN WITNESS WHEREOF, aaiPharma has caused this Agreement to be executed in its corporate name
by a duly authorized officer, and Consultant has set his hand and seal, as of the day and year
first above written. CONSULTANTBy:
    
    /s/ William L. Ginna, Jr.William L. Ginna, Jr.aaiPHARMA INC.By:
    
    /s/ Greg RayburnName: Greg Rayburn
Title: COO
Exhibit 32



On May 3, 2004, the Chief Executive Officer and Chief Financial Officer of Exult, Inc. (the Company) provided a written statement accompanying
the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2004 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. A copy of that written statement is set forth below as Exhibit 32. The information in Exhibit 32 shall
not be deemed filed under the Securities Exchange Act of 1934 or otherwise subject to liabilities thereunder. Furthermore, the information in Exhibit 32 shall not be deemed to be incorporated by reference into the filings of the Company
under the Securities Act of 1933.



Statement of the Chief Executive Officer
and Chief Financial Officer of Exult, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



This statement, dated May 3, 2004, is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter
63 of Title 18, United States Code), and accompanies the Quarterly Report on Form 10-Q filed by Exult, Inc. (the Issuer) with the Securities and Exchange Commission for the quarter ended September 30, 2003 (the Report).



We hereby certify that, to our knowledge, (a) the Report fully
complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (b) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.



This statement is given in our capacities as Chief Executive
Officer and Chief Financial Officer, respectively, of Exult, Inc.



/s/    James C. Madden, VJames C. Madden, V Chief Executive
Officer




/s/    John A. AdamsJohn A. Adams Chief Financial
Officer
Court of Appeals

Sixth Appellate District of Texas

JUDGMENT

Curtis Charles Reichle, Appellant

No. 06-14-00073-CR v.

The State of Texas, Appellee

Appeal from the 8th District Court of 

Hopkins County, Texas (Tr. Ct. No. 

1423783). Memorandum Opinion 

delivered by Justice Moseley, Chief Justice 

Morriss and Justice Burgess participating.

As stated in the Court’s opinion of this date, we find no error in the judgment of the court 

below. We affirm the judgment of the trial court.

We note that the appellant, Curtis Charles Reichle, has adequately indicated his inability 

to pay costs of appeal. Therefore, we waive payment of costs.

RENDERED JANUARY 30, 2015

BY ORDER OF THE COURT

JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST:

Debra K. Autrey, Clerk
AUSBON OSBORNE, V. THE 5TATE OF TEXAS NO. IN THE COURT OF CRIMINAL APPEALS 

# OFTEXaJ!!=PESVEDIN SEP162015 PRO SE MOTION REQUESTING LEAVE TO FILE AN ORIGINAL COPY OF THE -:;P;ETiIT--E0-N^FQ"R-^'DvES:EWE^EONARY--,RE VIEU~ 

## AbelAcosta,Cterf? TO THE HONORABLE COURT OF CRIMINAL APPEALS OF TEXAS COMES NOW the Appellant in the above-styled and numbered cause and 

### respectfullymoves this Honorable Court togrant leave to file an origi nal copy only of the Petition for Discretionary Review and in support thereof would shay to the Court the foiling: 1. The style and appeal number in the Amarillo Court of Appeals is: NO. 07-13-00156-CR V. The State of Texas. 2. The Appellant moves that, pursuant to Rule 2, Texas Rule of 

### Appellate Procedure, this Coiirt suspend Rule 9.3(b), Texas Rule of App ellate Procedure, that requires the filing of eleven (11) copies of the Petition for Discretionary Review with the Court. 

### 3. The facts relied upon to show good cause for this request are as follows: The Appellant is indigent and incarcerated and does not 

### have access to aphoto copier. The Appellant is presentlynot repres ented by counsel and intends to file a Pro Se Petition for Discretionary Review by inmate in the Texas Department of Criminal Justice system. ..T-h.e.-»A.p-pe.lJ..a-n-t-,,-A-t-j-s=b«o»n^Osfao-r-n-e,t-;r»e-Sip«eEt-fully thinks this Honorable 

### Courts kind assistance inregards to the above motion, and request in 

### the best interest of justice, the Court would consider granting this Appellant's motion. RESPECTFULLY submitted;



### (name/date)WHEREFORE, PREMISES CONSIDERED, the Appellant respectfully request that this Honorable Court grant leave to file an original copy only of the Petition.for Discretionary Review with the Court. Respectfully submitted



## /t 

# £ g-lJSr-lS (Signature/Date)

CERTIFICATE OF SERVICE The Appellant hereby certifies that a true and correct copy of the foregoing Motion has been mailed to the Office of the Criminal District Attorney for Tarrant County, Fort Worth, Texas, on the 

## dayof/Tt-t&US-7" ,2015.

(name) Ausbon Osborne TDC0#1853817 Hodge Unit 379 FM 2972 W Rusk, TX 75785-3666

# <9-2o-/t
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.,

 Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

January 30, 2012 

t0123 

Order 

 

January 30, 2012 

143919 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

v SC: 143919 

 COA: 305806 

Washtenaw CC: 10-001209-FC 

DAVID FRANKLIN SEARS, 

Defendant-Appellant. 

_________________________________________/ 

 On order of the Court, the application for leave to appeal the October 3, 2011 

order of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
**Exhibit 32.1**

 

CERTIFICATIONPURSUANT TO

18U.S.C. SECTION 1350,

ASADOPTED PURSUANT TO

SECTION906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the AnnualReport of NVE Corporation (the “Company”) on Form 10-KSB for the period endedMarch 31, 2004 as filed with the Securities and Exchange Commission on the datehereof (the “Report”), I, Daniel A. Baker, Chief Executive Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

 

1.     The Report fully complies withthe requirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

 

2.     The information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 

 
| Date: May 24, 2004                     |
|----------------------------------------|
|                                   |
| /s/ Daniel A. Baker                    |   |
| Daniel A. Baker                        |
| President and Chief Executive  Officer |

 

----
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 318 Introduced in Senate (IS)]

104th CONGRESS
  1st Session
                                 S. 318

To amend the Civil Rights Act of 1964 to make preferential treatment an 
         unlawful employment practice, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

             February 1 (legislative day, January 30), 1995

   Mr. Helms introduced the following bill; which was read twice and 
         referred to the Committee on Labor and Human Resourses

_______________________________________________________________________

                                 A BILL

 
To amend the Civil Rights Act of 1964 to make preferential treatment an 
         unlawful employment practice, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Civil Rights Restoration Act of 
1995''.

SEC. 2. PREFERENTIAL TREATMENT.

    (a) Unlawful Employment Practice.--Section 703(j) of the Civil 
Rights Act of 1964 (42 U.(j)) is amended to read as follows:
    ``(j)(1) It shall be an unlawful employment practice for any entity 
that is an employer, employment agency, labor organization, or joint 
labor-management committee subject to this title to grant preferential 
treatment to any individual or group with respect to selection for, 
discharge from, compensation for, or the terms, conditions, or 
privileges of, employment or union membership, on the basis of the 
race, color, religion, sex, or national origin of such individual or 
group, for any purpose, except as provided in subsection (e) or 
paragraph (2).
    ``(2) It shall not be an unlawful employment practice for an entity 
described in paragraph (1) to undertake affirmative action designed to 
recruit individuals of an underrepresented race, color, religion, sex, 
or national origin, to expand the applicant pool of the individuals 
seeking employment or union membership with the entity.''.
    (b) Construction.--Nothing in the amendment made by subsection (a) 
shall be construed to affect the authority of courts to remedy 
intentional discrimination under section 706(g) of the Civil Rights Act 
of 1964 (42 U.(g)).
                                 <all>
```
*

 This order and judgment is not binding precedent, except under the doctrines of

law of the case, res judicata, and collateral estoppel. The court generally disfavors the

citation of orders and judgments; nevertheless, an order and judgment may be cited under

the terms and conditions of 10th Cir. R. 36.3.

** After examining the briefs and appellate record, this panel has determined

unanimously that oral argument would not materially assist the determination of this

appeal. See Fed. R. App. P. 34(a); 10th Cir. R. 34.1.9. The case therefore is ordered

submitted without oral argument.

UNITED STATES COURT OF APPEALS

Filed 4/9/96 TENTH CIRCUIT

 

DAVID JAMES BIGPOND, Jr., )

)

Petitioner-Appellant, )

)

vs. ) No. 95-6257

) (D.C. No. CIV-94-1747-T)

RON CHAMPION, ) (W.D. Okla.)

)

Respondent-Appellee. )

 

ORDER AND JUDGMENT*

 

Before TACHA, BALDOCK, and BRISCOE, Circuit Judges.**

 

Petitioner David James Bigpond, Jr., a state prisoner proceeding pro se, brought a

28 U.S.C. § 2254 petition for a writ of habeas corpus attacking his conviction in

Oklahoma state court for robbery with firearms. Petitioner alleged that: (1) state

authorities denied him due process by convicting him based upon an unsubscribed,

unverified, and unfiled information, and, as a result (2) the state court had no jurisdiction
1

 We grant Petitioner’s motion for leave to proceed on appeal in forma pauperis. 

We grant Petitioner’s request for a certificate of probable cause and dispose of this case

on the merits. We deny Petitioner’s motion to compel the State of Oklahoma to produce

Petitioner’s pre-trial and trial transcripts and information sheet.

2

to entertain his guilty plea. The district court referred the petition to a magistrate judge. 

After a thorough review, the magistrate recommended Petitioner’s § 2254 petition

be denied. The magistrate liberally construed Petitioner’s due process claim as a claim

that his plea was not knowing and voluntary. The magistrate concluded Petitioner was

procedurally barred from challenging the voluntariness of his guilty plea in this, his third

petition for post-conviction relief. The magistrate also rejected Petitioner’s claim that the

district court lacked jurisdiction to entertain his guilty plea. The magistrate took judicial

notice of state court records which contained one information that was file stamped,

properly endorsed, and verified. The district court adopted the magistrate’s

recommendation and denied Petitioner’s § 2254 petition.

We have reviewed Petitioner’s brief, the district court’s order, the magistrate’s

recommendation, and the entire record on appeal. Based on our review, we find no

reversible error and affirm.1

AFFIRMED.

Entered for the Court

Bobby R. Baldock

Circuit Judge
evok-ex1025_826.htm



Exhibit 10.25

AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

THIS AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Amendment”) is made effective as of the 25th day of January, 2017, by and between Evoke Pharma, Inc. (the “Company”), and Matthew D’Onofrio (“Executive”).

 

WHEREAS, the Company and Executive are parties to that certain Amended and Restated Employment Agreement, effective as of June 7, 2013 (“Original Agreement”); and

WHEREAS, the Company and Executive desire to amend the Original Agreement on the terms and conditions set forth below.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties agree as follows:


	
1.
	
Section 3(b) of the Original Agreement.  The second sentence of Section 3(b) of the Original Agreement is hereby amended and restated to read as follows:





	

	
“For each year during the term of this Agreement, Executive’s target Annual Bonus shall be 45% of his base salary actually paid for such year.”





	
2.
	
Miscellaneous.  This Amendment shall be and is hereby incorporated in and forms a part of the Original Agreement.  All other terms and provisions of the Original Agreement shall remain unchanged except as specifically modified herein.  This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.  This Amendment shall be governed by and construed in accordance with the laws of the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.  The headings of the sections in this Amendment are inserted solely for the convenience of the parties and are not a part of and are not intended to govern, limit or aid in the construction of any term of provision hereof.  This Amendment may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.




(Signature Page Follows)

 



Exhibit 10.25

IN WITNESS WHEREOF, the parties have executed this Amendment as of the date(s) set forth below.

 


		
	
 
	
EVOKE PHARMA, INC.

	
 
	
 

	
Dated:  3-8-17
	
By:  /s/ David A. Gonyer

	
 
	
Name:  David A. Gonyer

Title:    Chief Executive Officer

	
 
	
 

	
 
	
EXECUTIVE

	
 
	
 

	
Dated:  3-13-17
	
/s/ Matthew D’Onofrio

Matthew D’Onofrio
[Federal Register Volume 89, Number 27 (Thursday, February 8, 2024)]
[Notices]
[Page 8681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02515]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--DP24-081, Effectiveness of 
Telehealth-based Glaucoma Detection Program Among High-risk Population 
Within Community Health Settings.
    Date: April 11, 2024.
    Time: 10 a.m.-6 p.m., EDT.
    Place: Teleconference/Web Conference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Catherine Barrett, Ph.D., 
Scientific Review Officer, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Highway, Mailstop S106-3, Atlanta, Georgia 
30341-3717. Telephone: (404) 718-7664; Email: <a href="/cdn-cgi/l/email-protection#0645446774746372724665626528616970"><span class="__cf_email__" data-cfemail="e7a4a5869595829393a7848384c9808891">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02515 Filed 2-7-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
II

104TH CONGRESS

1ST SESSION S. 499

To provide an exception to the coverage of State and local employees under

Social Security.

IN THE SENATE OF THE UNITED STATES

MARCH 6, 1995

Mr. JOHNSTON introduced the following bill; which was read twice and

referred to the Committee on Finance

A BILL

To provide an exception to the coverage of State and local

employees under Social Security.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. EXCEPTION TO COVERAGE OF STATE AND

4 LOCAL EMPLOYEES UNDER SOCIAL SECU5 RITY.

6 (a) EMPLOYMENT UNDER OASDI.—Subparagraph

7 (F) of section 210(a)(7) of the Social Security Act (42

8 U.S.C. 410(a)(7)) is amended—

9 (1) by striking ‘‘or’’ at the end of clause (iv),
2

•S 499 IS

1 (2) by inserting ‘‘or’’ at the end of clause (v),

2 and

3 (3) by inserting after clause (v) the following

4 new clause:

5 ‘‘(vi) by an individual who is charac6 terized as a part-time, seasonal, or tem7 porary employee by such retirement sys8 tem;’’.

9 (b) EMPLOYMENT UNDER FICA.—Subparagraph

10 (F) of section 3121(b)(7) of the Internal Revenue Code

11 of 1986 is amended—

12 (1) by striking ‘‘or’’ at the end of clause (iv),

13 (2) by inserting ‘‘or’’ at the end of clause (v),

14 and

15 (3) by inserting after clause (v) the following

16 new clause:

17 ‘‘(vi) by an individual who is charac18 terized as a part-time, seasonal, or tem19 porary employee by such retirement sys20 tem;’’.

21 (c) EFFECTIVE DATE.—The amendments made by

22 this section shall apply with respect to service performed

23 after December 31, 1995.

Æ